Opportunity

Federal Register #2026-17288

Bulk Manufacture Registration for Schedule I Controlled Substance by Kinetochem LLC

Buyer

Justice Department / Drug Enforcement Administration

Posted

August 25, 2026

Respond By

October 26, 2026

Identifier

2026-17288

NAICS

325412, 325199

This opportunity concerns Kinetochem LLC's application to become a registered bulk manufacturer of a Schedule I controlled substance, overseen by the Drug Enforcement Administration (DEA). - Government Buyer: - Drug Enforcement Administration (DEA), U.S. Department of Justice - OEMs and Vendors: - Kinetochem LLC (applicant and proposed manufacturer) - Products/Services Requested: - Bulk manufacture of 3,4-Methylenedioxy-N-methylcathinone (drug code 7540, Schedule I) - Intended use: Active Pharmaceutical Ingredient (API) for customers, research, and clinical trials - No other activity authorized for this drug code - Unique/Notable Requirements: - Registration is strictly for manufacturing the specified controlled substance as an API - DEA invites comments or objections from other registered bulk manufacturers and applicants - Focus is on compliance with controlled substance regulations and research/clinical trial support

Description

Kinetochem LLC has applied to be registered as a bulk manufacturer of basic classes of controlled substances. The application is a notice published by the Drug Enforcement Administration under the Justice Department. Registered bulk manufacturers and applicants may submit electronic comments or objections, and file written requests for a hearing on the application by October 26, 2026. The company plans to bulk manufacture the listed controlled substances as Active Pharmaceutical Ingredients for customers and for research and clinical trials.

View original listing